184066856	184066856	CD	B-NP	O
|	|	NN	I-NP	O
AH	AH	NN	I-NP	O
|	|	NN	I-NP	O
49993416	49993416	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5471175	5471175	CD	B-NP	O
|	|	CC	I-NP	O
2/11/2006	2/11/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
FEVER	FEVER	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/4/2006	6/4/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/3/2006	1/3/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
BORDA	BORDA	NNP	B-NP	O
,	,	,	O	O
WINFORD	WINFORD	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
OUTPATIENT	OUTPATIENT	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Glenn	Glenn	NNP	I-NP	O
Beshore	Beshore	NNP	I-NP	O
.	.	.	O	O

Fax	Fax	NN	B-NP	B-protein
number	number	NN	I-NP	O
973-069-1118	973-069-1118	CD	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

VRE	VRE	NN	B-NP	O
line	line	NN	I-NP	O
sepsis	sepsis	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
heel	heel	NN	I-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Type	Type	NN	B-NP	O
I	I	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

End-stage	End-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Fever	Fever	NNP	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
36-year-old	36-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	O
I	I	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
chronic	chronic	JJ	B-NP	O
skin	skin	NN	I-NP	O
ulcers	ulcer	NNS	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
fevers	fever	NNS	B-NP	O
to	to	TO	B-PP	O
101	101	CD	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
rigors	rigor	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	B-protein
abdominal	abdominal	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
referred	refer	VBN	I-VP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
questioning	question	VBG	B-VP	O
reports	report	NNS	B-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
abdominal	abdominal	JJ	B-NP	O
cramping	cramping	NN	I-NP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
chills	chill	NNS	B-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
became	become	VBD	B-VP	O
febrile	febrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
infection	infection	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
referred	refer	VBN	I-VP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
.	.	.	O	O

EMERGENCY	EMERGENCY	NN	B-NP	O
DEPARTMENT	DEPARTMENT	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
ceftriaxone	ceftriaxone	NN	B-NP	O
,	,	,	O	O
gentamicin	gentamicin	NN	B-NP	O
and	and	CC	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
regular	regular	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
morphine	morphine	NN	B-NP	O
IV	IV	CD	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Notable	Notable	NNP	B-NP	O
for	for	IN	B-PP	O
headaches	headache	NNS	B-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
reports	report	VBZ	B-VP	O
is	be	VBZ	B-VP	O
better	good	JJR	B-ADJP	O
since	since	IN	B-PP	O
having	have	VBG	B-VP	O
dialysis	dialysis	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
three-pillow	three-pillow	JJ	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
melena	melena	NN	B-NP	O
,	,	,	O	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
or	or	CC	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Type	Type	NN	B-NP	O
I	I	CD	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
dermal	dermal	JJ	I-NP	O
ulcers	ulcer	NNS	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
,	,	,	O	O
legally	legally	RB	B-NP	O
blind	blind	JJ	I-NP	O
,	,	,	I-NP	O
gastropathy	gastropathy	JJ	I-NP	O
,	,	,	I-NP	O
cardiac	cardiac	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
,	,	,	O	O
seizure	seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
hepatomegaly	hepatomegaly	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
excision	excision	NN	I-NP	O
of	of	IN	B-PP	O
infected	infected	JJ	B-NP	O
bone	bone	NN	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
heel	heel	NN	I-NP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
causes	cause	VBZ	B-VP	O
tongue	tongue	NN	B-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

Codeine	Codeine	NN	B-NP	O
,	,	,	I-NP	O
erythromycin	erythromycin	NN	I-NP	O
,	,	,	I-NP	O
beef	beef	NN	I-NP	O
and	and	CC	I-NP	O
pork	pork	NN	I-NP	O
insulin	insulin	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Neurontin	Neurontin	NNP	B-NP	O
,	,	,	O	O
Keppra	Keppra	NNP	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
Toprol	Toprol	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
notably	notably	RB	B-NP	O
Lantus	Lantus	NN	I-NP	O
and	and	CC	I-NP	O
NPH	NPH	NN	I-NP	B-protein
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
four	four	CD	B-NP	O
children	child	NNS	I-NP	O
ages	age	NNS	I-NP	O
5	5	CD	B-NP	O
through	through	IN	I-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
no	no	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
,	,	,	I-NP	O
alcohol	alcohol	NN	I-NP	O
or	or	CC	I-NP	O
IV	IV	CD	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
mother	mother	NN	I-NP	O
is	be	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
watching	watch	VBG	B-VP	O
her	her	PRP$	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
103.3	103.3	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
92	92	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
200/95	200/95	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
black	black	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
skin	skin	NN	I-NP	O
ulcers	ulcer	NNS	I-NP	O
notably	notably	RB	B-ADVP	O
over	over	IN	B-PP	O
her	her	PRP$	B-NP	O
trunk	trunk	NN	I-NP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
and	and	CC	I-NP	O
accommodation	accommodation	NN	I-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
horizontal	horizontal	JJ	B-NP	O
nystagmus	nystagmus	NN	I-NP	O
,	,	,	O	O
sclerae	sclerae	NNS	B-NP	O
are	be	VBP	B-VP	O
anicteric	anicteric	JJ	B-ADJP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
:	:	:	O	O
Faint	Faint	NNP	B-NP	O
right	right	JJ	I-NP	O
basilar	basilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
II/VI	II/VI	NNP	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Carotids	Carotid	NNS	B-NP	B-protein
2	2	CD	B-NP	I-protein
+	+	SYM	B-VP	O
without	without	IN	B-PP	O
bruit	bruit	NN	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Decreased	Decrease	VBN	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
slightly	slightly	RB	I-NP	O
distended	distended	JJ	I-NP	O
,	,	,	I-NP	O
mildly	mildly	RB	I-NP	O
tender	tender	NN	I-NP	O
with	with	IN	B-PP	O
deep	deep	JJ	B-NP	O
palpation	palpation	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
rebound	rebound	NN	I-NP	O
or	or	CC	I-NP	O
guarding	guarding	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
1-2	1-2	CD	I-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
heel	heel	NN	B-NP	O
open	open	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
with	with	IN	B-PP	O
foul	foul	JJ	B-NP	O
odor	odor	NN	I-NP	O
and	and	CC	O	O
surrounding	surround	VBG	B-VP	O
erythema	erythema	NN	B-NP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-NP	O
examination	examination	NN	I-NP	O
grossly	grossly	RB	B-ADJP	O
nonfocal	nonfocal	JJ	I-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
133	133	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.5	4.5	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
45	45	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
8.2	8.2	CD	I-NP	O
.	.	.	O	O

Serum	Serum	NN	B-NP	B-protein
glucose	glucose	NN	I-NP	I-protein
507	507	CD	I-NP	I-protein
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
14.4	14.4	CD	B-NP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
bands	band	NNS	I-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	B-protein
30.3	30.3	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
525	525	CD	B-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
liver	liver	NN	I-NP	O
function	function	NN	I-NP	O
test	test	NN	I-NP	O
,	,	,	O	O
lipase	lipase	NN	B-NP	O
29	29	CD	I-NP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
hCG	hCG	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
1.6	1.6	CD	I-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
positive	positive	JJ	I-ADJP	O
.	.	.	O	O

STUDIES	STUDIES	NNS	B-NP	O
:	:	:	O	O
Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
enlarged	enlarged	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
silhouette	silhouette	NN	I-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
pericardial	pericardial	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
and	and	CC	O	O
bibasilar	bibasilar	JJ	B-NP	O
subsegmental	subsegmental	JJ	I-NP	O
atelectasis	atelectasis	NN	I-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
foot	foot	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
calcaneus	calcaneus	NN	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
retroperitoneal	retroperitoneal	JJ	I-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
nodules	nodule	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
attenuation	attenuation	NN	I-NP	O
foci	focus	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
of	of	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
significance	significance	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
85	85	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
with	with	IN	B-PP	O
isolated	isolate	VBN	B-NP	O
T-wave	T-wave	NN	I-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
V1	V1	NN	B-NP	B-protein
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
wound	wound	NN	I-NP	O
debridement	debridement	NN	I-NP	O
left	leave	VBD	B-VP	O
heel	heel	NN	B-NP	O
4/10/06	4/10/06	CD	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Ira	Ira	NNP	I-NP	O
Pollart	Pollart	NNP	I-NP	O
,	,	,	O	O
vascular	vascular	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
tunneled	tunnel	VBD	B-VP	O
catheter	catheter	NN	B-NP	B-protein
placement	placement	NN	I-NP	I-protein
left	leave	VBD	B-VP	I-protein
chest	chest	NN	B-NP	I-protein
1/27/06	1/27/06	CD	I-NP	I-protein
by	by	IN	B-PP	O
interventional	interventional	JJ	B-NP	O
radiology	radiology	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
Line	Line	NN	B-NP	O
sepsis	sepsis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
broad-spectrum	broad-spectrum	NN	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
and	and	CC	O	O
initially	initially	RB	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
ceftazidime	ceftazidime	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
clindamycin	clindamycin	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
gentamicin	gentamicin	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
transthoracic	transthoracic	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
valvular	valvular	JJ	B-NP	O
vegetation	vegetation	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
stigmata	stigmata	NN	I-NP	O
of	of	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
from	from	IN	B-PP	O
8/17/2006	8/17/2006	CD	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
resistant	resistant	JJ	I-NP	O
enterococcus	enterococcus	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
linezolid	linezolid	NN	B-NP	O
and	and	CC	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
to	to	TO	B-VP	O
cover	cover	VB	I-VP	O
for	for	IN	B-PP	O
anaerobes	anaerobe	NNS	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
heel	heel	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
tunneled	tunnel	VBN	I-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	B-DNA
day	day	NN	I-NP	I-DNA
#	#	#	B-NP	I-DNA
2	2	CD	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
line	line	NN	B-NP	O
sepsis	sepsis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
and	and	CC	O	O
will	will	MD	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
21-day	21-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
linezolid	linezolid	NN	B-NP	O
for	for	IN	B-PP	O
VRE	VRE	NN	B-NP	O
line	line	NN	I-NP	O
sepsis	sepsis	NN	I-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
show	show	VBP	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
left	left	JJ	I-NP	O
heel	heel	NN	I-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
plain	plain	JJ	B-NP	O
films	film	NNS	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Vascular	Vascular	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
debridement	debridement	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
heel	heel	NN	I-NP	O
on	on	IN	B-PP	O
4/10/06	4/10/06	CD	B-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Angeloni	Angeloni	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Kalan	Kalan	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
most	most	RBS	I-VP	O
likely	likely	RB	I-VP	O
need	need	VB	I-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
below-the-knee	below-the-knee	JJ	I-NP	O
amputation	amputation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
most	most	JJS	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
wound	wound	NN	I-NP	O
culture	culture	NN	I-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
Morganella	Morganella	NNP	B-NP	O
morganii	morganii	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
discussion	discussion	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	JJ	I-NP	O
team	team	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
positive	positive	JJ	I-NP	O
wound	wound	NN	I-NP	O
culture	culture	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
vacuum	vacuum	NN	I-NP	O
dressing	dressing	NN	I-NP	O
was	be	VBD	B-VP	O
temporarily	temporarily	RB	I-VP	O
placed	place	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
wound	wound	NN	I-NP	O
and	and	CC	O	O
currently	currently	RB	B-ADVP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
t.i.d.	t.i.d.	NN	B-NP	O
wet-to-dry	wet-to-dry	JJ	I-NP	O
dressings	dressing	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
that	that	WDT	B-NP	O
could	could	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
compatible	compatible	JJ	B-ADJP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
early	early	JJ	I-NP	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
low	low	JJ	I-NP	O
grade	grade	NN	I-NP	O
fevers	fever	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
10	10	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
renally	renally	RB	B-NP	O
dosed	dose	VBN	I-NP	O
Levaquin	Levaquin	NNP	I-NP	O
to	to	TO	B-VP	O
cover	cover	VB	I-VP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
community	community	NN	I-NP	O
acquired	acquire	VBD	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
fevers	fever	NNS	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
abscess	abscess	NN	I-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
intraabdominal	intraabdominal	JJ	I-NP	O
acute	acute	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
her	her	PRP$	B-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
catheter	catheter	NN	I-NP	O
removal	removal	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
negative	negative	JJ	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
from	from	IN	B-PP	O
5/16/06	5/16/06	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Interventional	Interventional	NNP	I-NP	O
Radiology	Radiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
placed	place	VBD	B-VP	O
another	another	DT	B-NP	O
left	left	JJ	I-NP	O
chest	chest	NN	I-NP	O
tunneled	tunnel	VBD	B-VP	O
hemodialysis	hemodialysis	NN	B-NP	O
catheter	catheter	NN	I-NP	O
on	on	IN	B-PP	O
1/27/06	1/27/06	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Nephrocaps	Nephrocaps	NNP	B-NP	O
,	,	,	O	O
PhosLo	PhosLo	NNP	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Plavix	Plavix	NN	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
admission	admission	NN	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
enlarged	enlarged	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
silhouette	silhouette	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
transthoracic	transthoracic	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
that	that	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
trivial	trivial	JJ	I-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
tamponade	tamponade	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
low-dose	low-dose	JJ	B-NP	O
beta-blockade	beta-blockade	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
periods	period	NNS	B-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
did	do	VBD	B-VP	O
improve	improve	VB	I-VP	O
with	with	IN	B-PP	O
up-titration	up-titration	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
and	and	CC	I-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Toprol-XL	Toprol-XL	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	O	O
electrolytes	electrolyte	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nutrition	nutrition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
restricted	restricted	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
hyperkalemia	hyperkalemia	NN	B-NP	O
of	of	IN	B-PP	O
6.3	6.3	CD	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
appropriately	appropriately	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hyperkalemia	hyperkalemia	NN	I-NP	O
did	do	VBD	B-VP	O
improve	improve	VB	I-VP	O
with	with	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
difficult	difficult	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
IV	IV	CD	I-NP	O
access	access	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
refuse	refuse	VB	I-VP	O
a	a	DT	B-NP	O
central	central	JJ	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Neurology	Neurology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
seizure	seizure	NN	I-NP	O
disorder	disorder	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Keppra	Keppra	NNP	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
had	have	VBD	B-VP	O
elevation	elevation	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
to	to	TO	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
500	500	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
drip	drip	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
off	off	RP	B-PRT	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
periods	period	NNS	B-NP	O
of	of	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
amps	amp	NNS	B-NP	O
of	of	IN	B-PP	O
D50	D50	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
adjusted	adjust	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	B-DNA
25	25	CD	I-NP	I-DNA
once	once	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
and	and	CC	I-NP	O
NPH	NPH	NN	I-NP	B-protein
12	12	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
once	once	RB	B-ADVP	O
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
before	before	IN	B-PP	O
each	each	DT	B-NP	O
meal	meal	NN	I-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
again	again	RB	B-ADVP	O
had	have	VBD	B-VP	O
periods	period	NNS	B-NP	O
of	of	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
overnight	overnight	RB	B-ADVP	O
on	on	IN	B-PP	O
1/27/06	1/27/06	CD	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
NPH	NPH	NN	B-NP	B-protein
12	12	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcu	subcu	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
NovoLog	NovoLog	NNP	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
periods	period	NNS	B-NP	O
of	of	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
.	.	.	O	O

SHe	SHe	NNP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
units	unit	NNS	I-NP	O
sc	sc	NN	I-NP	O
qam	qam	NN	I-NP	O
and	and	CC	O	O
qac	qac	NN	B-NP	O
and	and	CC	I-NP	O
qhs	qh	NNS	I-NP	O
coverage	coverage	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
humalog	humalog	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
followup	followup	VB	I-VP	O
at	at	IN	B-PP	O
Bois	Bois	NNP	B-NP	O
Tham	Tham	NNP	I-NP	O
General	General	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
Pneumoboots	Pneumoboot	NNS	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
and	and	CC	I-NP	O
stable	stable	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
retroperitoneal	retroperitoneal	JJ	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
worked	work	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
may	may	MD	B-VP	O
represent	represent	VB	I-VP	O
inflammatory	inflammatory	JJ	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
line	line	NN	B-NP	O
sepsis	sepsis	NN	I-NP	O
and	and	CC	I-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
however	however	RB	B-ADVP	O
,	,	,	O	O
malignancy	malignancy	NN	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
excluded	exclude	VBN	I-VP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
nodules	nodule	NNS	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
evaluate	evaluate	VB	I-VP	O
these	these	DT	B-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
low-attenuation	low-attenuation	JJ	I-NP	O
area	area	NN	I-NP	O
seen	see	VBN	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
on	on	IN	B-PP	O
CT	CT	NN	B-NP	O
scan	scan	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
discussion	discussion	NN	B-NP	O
with	with	IN	B-PP	O
Radiology	Radiology	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
further	further	JJ	B-NP	O
imaging	imaging	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
either	either	CC	O	O
CT	CT	NN	B-NP	O
enterography	enterography	NN	I-NP	O
or	or	CC	O	O
small-bowel	small-bowel	JJ	B-NP	O
follow-through	follow-through	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
feel	feel	VB	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
area	area	NN	I-NP	O
represented	represent	VBD	B-VP	O
an	an	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
pathology	pathology	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Wound	Wound	JJ	B-NP	O
care	care	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
requires	require	VBZ	B-VP	O
t.i.d.	t.i.d.	RB	B-ADVP	O
wet-to-dry	wet-to-dry	JJ	B-NP	O
dressing	dress	VBG	I-NP	O
changes	change	NNS	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
heel	heel	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Vascular	Vascular	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
at	at	IN	B-PP	O
either	either	CC	O	O
Ow	Ow	NNP	B-NP	O
Community	Community	NNP	I-NP	O
Hospitals	Hospitals	NNP	I-NP	O
,	,	,	O	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
preference	preference	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
have	have	VB	I-VP	O
dry	dry	JJ	B-NP	O
sterile	sterile	JJ	I-NP	O
dressings	dressing	NNS	I-NP	O
placed	place	VBN	B-VP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
multiple	multiple	JJ	I-NP	O
open	open	JJ	I-NP	O
dermal	dermal	JJ	I-NP	O
ulcers	ulcer	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
chronic	chronic	JJ	B-ADJP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
homeVNA	homeVNA	NN	B-NP	O
services	service	NNS	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	JJ	B-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
either	either	DT	B-NP	O
Vascular	Vascular	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
at	at	IN	B-PP	O
Tho	Tho	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
or	or	CC	B-PP	O
with	with	IN	B-PP	O
Vascular	Vascular	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Sehr	Sehr	NNP	I-NP	O
at	at	IN	B-PP	O
317-001-4753	317-001-4753	CD	B-NP	O
at	at	IN	B-PP	O
Rohall	Rohall	NNP	B-NP	O
Health	Health	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Cedrick	Cedrick	NNP	I-NP	O
Packingham	Packingham	NNP	I-NP	O
,	,	,	O	O
829-459-7212	829-459-7212	CD	B-NP	O
at	at	IN	B-PP	O
Eewood	Eewood	NNP	B-NP	O
Alum	Alum	NNP	I-NP	O
Lopela	Lopela	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Nephrology	Nephrology	NNP	I-NP	O
Department	Department	NNP	I-NP	O
after	after	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
from	from	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
?	?	.	O	O
?	?	.	O	O
__	__	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
at	at	IN	B-PP	O
Boxsan	Boxsan	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
four	four	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
rehab	rehab	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
undergo	undergo	VB	I-VP	O
hemodialysis	hemodialysis	NN	B-NP	O
at	at	IN	B-PP	O
Oview	Oview	NNP	B-NP	O
Cooau	Cooau	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
,	,	,	O	O
430-609-4274	430-609-4274	CD	B-NP	O
in	in	IN	B-PP	O
Ale	Ale	NNP	B-NP	O
E	E	NNP	I-NP	O
Fre	Fre	NNP	I-NP	O
La	La	NNP	I-NP	O
Ankrance	Ankrance	NNP	I-NP	O
on	on	IN	B-PP	O
Mondays	Mondays	NNP	B-NP	O
,	,	,	O	O
Wednesdays	Wednesdays	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Fridays	Friday	NNS	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
every	every	DT	B-NP	O
four	four	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
headache	headache	NN	B-NP	O
,	,	,	O	O
Keppra	Keppra	NNP	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
PhosLo	PhosLo	NN	B-NP	O
667	667	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Nephrocaps	Nephrocap	VBZ	B-VP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	O	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Linezolid	Linezolid	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

for	for	IN	B-PP	O
18	18	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
8	8	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	I-protein
once	once	RB	I-ADVP	I-protein
every	every	DT	B-NP	I-protein
morning	morning	NN	I-NP	I-protein
please	please	NN	I-NP	I-protein
take	take	VBP	B-VP	O
one-half	one-half	JJ	B-NP	O
dose	dose	NN	I-NP	O
if	if	IN	B-SBAR	O
not	not	RB	O	O
eating	eat	VBG	B-VP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
every	every	DT	B-NP	O
four	four	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	O	O
hold	hold	VB	B-VP	O
if	if	IN	B-SBAR	O
sedation	sedation	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Humalog	Humalog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
If	If	IN	B-SBAR	O
glucose	glucose	NN	B-NP	O
0-70	0-70	CD	I-NP	O
,	,	,	O	O
call	call	NN	B-NP	O
physician	physician	NN	I-NP	O
and	and	CC	O	O
drink	drink	VB	B-VP	O
orange	orange	NN	B-NP	O
juice	juice	NN	I-NP	O
;	;	:	O	O
if	if	IN	B-SBAR	O
fingerstick	fingerstick	NN	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
200	200	CD	I-NP	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
zero	zero	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
Humalog	Humalog	NNP	B-NP	O
;	;	:	O	O
if	if	IN	B-SBAR	O
fingerstick	fingerstick	NN	B-NP	O
201-250	201-250	CD	I-NP	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
Humalog	Humalog	NNP	B-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
;	;	:	O	O
if	if	IN	B-SBAR	O
fingerstick	fingerstick	NN	B-NP	O
251-300	251-300	CD	I-NP	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
Humalog	Humalog	NNP	B-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
;	;	:	O	O
if	if	IN	B-SBAR	O
fingerstick	fingerstick	NN	B-NP	O
301-350	301-350	CD	I-NP	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
Humalog	Humalog	NNP	B-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
;	;	:	O	O
if	if	IN	B-SBAR	O
fingerstick	fingerstick	NN	B-NP	O
351-400	351-400	CD	I-NP	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
Humalog	Humalog	NNP	B-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
;	;	:	O	O
if	if	IN	B-SBAR	O
fingerstick	fingerstick	NN	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
,	,	,	O	O
take	take	VB	B-NP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
Humalog	Humalog	NNP	B-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
physician	physician	NN	B-NP	O
if	if	IN	B-SBAR	O
fingerstick	fingerstick	NN	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
.	.	.	O	O

Levaquin	Levaquin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qday	qday	NN	I-NP	O
X	X	NN	I-NP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
3-9054961	3-9054961	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Elvis	Elvis	NNP	B-NP	O
Bilello	Bilello	NNP	I-NP	O
Nephrology	Nephrology	NNP	I-NP	O
Department	Department	NNP	I-NP	O
Erdosher	Erdosher	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
HAVERMANN	HAVERMANN	NNP	B-NP	O
,	,	,	O	O
HUNG	HUNG	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SUFFIELD	SUFFIELD	NNP	B-NP	O
,	,	,	O	O
SONNY	SONNY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9344456	9344456	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
2/18/06	2/18/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/18/06	2/18/06	CD	B-NP	O

